Resources

Arrowg+ard Blue Plus™ Protection Clinical Resources
Technology Overview Video
Request More Information
USA / Product Areas / Vascular Access / Central Access / Percutaneous Sheath Introducer (PSI)
Product Overview Benefits Features Kitting Options Order Information

Arrowg+ard Blue® PSI

Optimal Access with Clinican-Trusted Chlorhexidine Protection

The Arrowg+ard Blue™ Percutaneous Sheath Introducer (PSI) is built for precision and performance in high-acuity settings—offering access for hemodynamic monitoring and large-volume fluid administration when every second counts.

Designed with a hemostasis valve for secure placement and seamless integration of additional devices—like a thermodilution catheter or PSI Companion Catheter. The PSI Companion Catheter enables up to three additional lumens for advanced patient management.

Arrowg+ard Blue™ Antimicrobial Protection is designed to reduce colonization and help prevent catheter-related bloodstream infections (CRBSIs).1 At the core of the protection is Chlorhexidine—a proven, broad-spectrum antimicrobial. By disrupting the cell membrane of microbes, Chlorhexidine provides defense against a wide range of pathogens.2

Chlorhexidine-based Protection backed by 30+ clinical studies.13


Chlorhexidine Antimicrobial Protection Offers:
  • Broad-Spectrum Protection against:
    • Gram-positive bacteria
    • Gram-negative bacteria
    • Fungi
  • Fast Acting
    Bacterial uptake typically within 20 seconds2
  • External Protection from Tip to Juncture Hub
    Chlorhexidine-based protection on the external surface of the catheter4

Contact Us to Learn More
View Our Product Catalog

  • With broader spectrum protection than antibiotics and a faster kill rate than other antimicrobials (e.g., povidone-iodine).2
  • External protection on the catheter surface.4

  • Arrowg+ard Blue™ Protection is supported by 30+ clinical studies.13
  • Chlorhexidine kills organisms and protects against microbial colonization and, subsequently biofilm development1

  • Market-leading technology trusted by clinicians and widely adopted across ICUs, EDs, and ORs.14
  • Received the highest levels of recommendation by the CDC9, INS10, SHEA11 and APIC12.
  • Available in Arrow™ ErgoPack™ Complete Kits designed to support standardization, protocol alignment, and confidence at the bedside.

Product Features

Equip your team with the access, flexibility, and antimicrobial protection they need for confident hemodynamic monitoring in high-acuity settings.

Chlorhexidine-based Protection backed by 30+ clinical studies.13

Hemostasis Valve
One way valve designed to stop blood leakage while allowing catheters or wires to pass through
Arrow-Flex™ Feature
Flexes without kinking to support consistent monitoring during movement
Arrowg+ard Blue™ Protection
Chlorhexidine-based antimicrobial protection on the catheter’s external surface
Side Arm
Enables dual access for procedural efficiency

Arrow™ ErgoPack™ Complete Kit

Each Arrow™ ErgoPack™ Complete Kit includes the components needed to support maximal barrier precautions—helping clinicians comply with evidence-based guidelines while improving efficiency and reducing procedural variability.9-12, 15


Order Information

Product

Description

CDC-29803-XN1A

AGB PSI 8.5Fr x 10CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-29803-XCN1A

AGB PSI 8.5Fr x 10CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing

CDC-29903-XN1A

AGB PSI 9Fr x 10CM ErgoPack™ Complete Kit with Tegaderm™ IV Advance + BIOPATCH®

CDC-29903-XCN1A

AGB PSI 9Fr x 10CM ErgoPack™ Complete Kit with Tegaderm™ CHG IV Securement Dressing


Want to learn more or schedule a Arrowg+ard Blue™ PSI demo/trial?

References:

  1. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters A. Bach, H. Schmidt, B. BSttiger, B. Schreiber, H. Bdhrer, J. Motsch, E. Martin and H. G. Sonntag. Journal of Antimicrobial Chemotherapy. 1996; 37: 315-322.
  2. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147-179. doi:10.1128/CMR.12.1.147
  3. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K940079
  4. AGB PSI IFU - I-09880-122C.
  5. Rosenthal VD, Yin R, Jin Z, et al. Multicenter, Multinational, Prospective Cohort Study of the Impact of Chlorhexidine Impregnated vs. Plain Central Lines on Central Line-associated Bloodstream Infections. American Journal of Infection Control. 2025;53(8):862-868. doi:https://doi.org/10.1016/j.ajic.2025.03.002
  6. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. Am J Infect Control. 2014;42(3):321-324. doi:10.1016/j.ajic.2013.09.022
  7. Lorente L, Lecuona M, Jiménez A, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. Am J Infect Control. 2014;42(10):1130-1132.doi:10.1016/j.ajic.2014.06.027
  8. Lorente L, Lecuona M, Jiménez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. Am J Infect Control. 2016;44(12):1526-1529. doi:10.1016/j.ajic.2016.04.236
  9. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). Atlanta, GA: Centers for Disease Control and Prevention; 2017.
  10. Nickel B, Gorski LA, Kleidon TM, et al. Infusion therapy standards of practice. J InfusNurs. 2024;47(suppl1):S1-S285.
  11. Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals. SHEA. Accessed January 29, 2024. https://shea-online.org/compendium-of-strategies-to-prevent-healthcare-associated-infections-in-acute-care-hospitals
  12. Preventing Catheter-Associated Bloodstream Infections (CABSI) in Adults.; 2025. Accessed June 23, 2025. https://apic.org/wp-content/uploads/2025/06/2025-CABSI-Implementation-Guide-004.pdf
  13. Arrowg+ard Blue™ Protection Clinical References. MC-004390. Available from Teleflex.
  14. 2024 IQVIA PSI Market share data on file.
  15. Arrow™ ErgoPack™ Complete Claims Matrix. MC-005776 Rev 1.
Rx only

Contraindication: Contraindication: The Arrowg+ard Blue™ PSI is contraindicated for patients with known hypersensitivity to chlorhexidine and silver sulfadiazine and/or sulfa drugs.

Refer to package insert provided with the product for complete warnings, indications, contraindications, precautions, potential complications and instructions for use.

BIOPATCH is a registered trademark of Johnson & Johnson. ChloraPrep is a registered trademark of Becton, Dickinson and Company. 3M and Tegaderm are registered trademarks of 3M.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue, Arrow-Flex, ErgoPack and GlideWheel are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. MC-011052
Want to learn more?
We want to connect with you.
Request More Information